Results 141 to 150 of about 2,649 (175)

Multimodal imaging in neuro-ophthalmology. [PDF]

Indian J Ophthalmol
Kumar M, Shah K, Saravanan VR, Chacko R, Jaju S, Shah VM.   +5 more
europepmc   +1 more source

Investigating the Link Between Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Non-arteritic Ischemic Optic Neuropathy: A Case Report of Semaglutide-Induced Optic Neuropathy. [PDF]

Cureus
Bakheet M, Chaudhary A.
europepmc   +1 more source

Semaglutide and Non-arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Narrative Synthesis. [PDF]

AACE Endocrinol Diabetes
Eisa N, Barood O.
europepmc   +1 more source

Non-Arteritic Anterior Ischemic Optic Neuropathy Before and During the COVID-19 Pandemic: A Retrospective Comparative Study. [PDF]

Clin Ophthalmol
Chaitanuwong P, Piankaew A.
europepmc   +1 more source

GLP-1 Receptor Agonists or SGLT2 Inhibitors and Nonarteritic Anterior Ischemic Optic Neuropathy.

JAMA Netw Open
Choi T, Al-Aly Z, Xie Y.
europepmc   +1 more source

The Benefits and Risks of Glucagon-Like Peptide-1 Receptor Agonists on Ocular Diseases: A Narrative Review. [PDF]

Cureus
Huang JXF, Wu J, Ahmad H, Li J, Joshi S, Yousaf A, Pemminati R, Pemminati S.   +7 more
europepmc   +1 more source

Editorial: Incretin-based therapies: economic sustainability and health impact in the global management of metabolic syndrome. [PDF]

Front Pharmacol
Provenzani A, Mueller T, Mattina A.
europepmc   +1 more source

Sight Unseen: Glucagon-Like Peptide-1 (GLP-1) Agonism Therapy and Nonarteritic Anterior Ischemic Optic Neuropathy. [PDF]

Cureus
Barnett MJ, Ibe F, Lam J.
europepmc   +1 more source

New-Onset Nonarteritic Anterior Ischemic Optic Neuropathy and Initiators of Semaglutide in US Veterans With Type 2 Diabetes.

JAMA Ophthalmol
Heberer K, Bress AP, Cogill S, Maldonado AI, Kim SH, Nallamshetty S, Chen YQ, Shih MC, Lynch JA, Lee JS.   +9 more
europepmc   +1 more source